Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
Completed · Phase 3
Conditions studied: Heroin Dependence
In brief
The purpose of this study is to compare liquid and tablet buprenorphine formulations.
Key facts
- Study ID
- NCT00000302
- Run by
- National Institute on Drug Abuse (NIDA)
- People needed
- 0
- Last updated by the study team
- 2005-11-07
Who can join
Age: 21 and older, up to 50. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- M/F ages 21-50. Opiate dependence according to DSM-IV criteria. Currently enrolled in the outpatient protocol comparing liquid and tablet formulations of Buprenorphine. Agreeable to conditions of study and signed informed consent.
You may not qualify if…
- Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative-hypnotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.
Where it is running
- Friends Research Institute — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.